menu
    • menu

    Company profile for Dompe Farmaceutici

    NEW Drugs in Dev: 12
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dompé is a privately owned biopharmaceutical company with 130 years of experience. Headquartered in Milan, we operate in Boston, San Francisco, and Shanghai. Dompé is committed to medical and scientific advancement, through our own research and open innovation ecosystem. We have developed the first application of rhNGF (recombinant human Nerve Growth Factor) as a commercial therapy. Dompé's rhNGF is the first and only phar...
    Dompé is a privately owned biopharmaceutical company with 130 years of experience. Headquartered in Milan, we operate in Boston, San Francisco, and Shanghai. Dompé is committed to medical and scientific advancement, through our own research and open innovation ecosystem. We have developed the first application of rhNGF (recombinant human Nerve Growth Factor) as a commercial therapy. Dompé's rhNGF is the first and only pharmacologic treatment specifically indicated for Neurotrophic Keratitis, approved by the FDA and EMA.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dompe FarmaceuticiItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Via Santa Lucia, 6 20122 Milano
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.dompe.com/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dompe/life/d4bfc13c-fc7e-4efa-8dc2-262966727dae/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dompé Enrolls First Patient Intranasal NGF Cerebral Palsy Study
    Dompé Enrolls First Patient Intranasal NGF Cerebral Palsy Study

    30 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260326265178/en/Domp-Announces-First-Patient-Enrolled-in-New-Study-of-Intranasal-NGF-in-Cerebral-Palsy

    BUSINESSWIRE
    30 Mar 2026
    Share Share
    Dompé Starts Phase 3 Isocyclosporin Trial for Atopic Dermatitis
    Dompé Starts Phase 3 Isocyclosporin Trial for Atopic Dermatitis

    16 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251215885369/en/Domp-Doses-First-Patients-in-Europe-and-US-in-Phase-3-Study-of-Isocyclosporin-for-Atopic-Keratoconjunctivitis

    BUSINESSWIRE
    16 Dec 2025
    Share Share
    Dompe Farmaceutici's Biologic Oxervate (cenegermin) Receives Approval in the U.S.
    Dompe Farmaceutici's Biologic Oxervate (cenegermin) Receives Approval in the U.S.

    20 Oct 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761094

    FDA
    20 Oct 2023
    Share Share
    Eni and Dompe farmaceutici join forces for health research
    Eni and Dompe farmaceutici join forces for health research

    11 Oct 2023

    // ECONOMIC TIMES

    https://www.indianpharmapost.com/news/eni-and-dompe-farmaceutici-join-forces-for-health-research-14773

    ECONOMIC TIMES
    11 Oct 2023
    Share Share
    Dompé farmaceutici Appoints Shannon K. Sullivan as CCO Biotech
    Dompé farmaceutici Appoints Shannon K. Sullivan as CCO Biotech

    10 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231010466159/en

    BUSINESSWIRE
    10 Oct 2023
    Share Share
    Dompe : New Published Data Point to Spike Protein Interactions with Estrogen
    Dompe : New Published Data Point to Spike Protein Interactions with Estrogen

    30 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/dompe-new-published-data-point-to-spike-protein-interactions-with-estrogen-receptors-as-a-cause-for-coagulopathy-in-covid-19-patients-signaling-sex-effects-and-a-path-to-improved-vaccines-301690590.html

    PRNEWSWIRE
    30 Nov 2022
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search